HYUGA PRIMARY CARE Co.,Ltd. (7133) AI Stock Analysis

• Market Cap: ¥7.82B
• Dividend Yield: 1.8%
• Average Volume (3M): 16.77K
• Price to Earnings (P/E): 13.4
• Beta (1Y): 0.53
• Revenue Growth: 18.58%
• EPS Growth: -6.30%
• Country: JP
• Employees: 544
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 15.51
• Shares Outstanding: 7,279,000
• 10 Day Avg. Volume: 17,690
• 30 Day Avg. Volume: 16,766
• PEG Ratio: 0.23
• Price to Book (P/B): 4.35
• Price to Sales (P/S): 1.03
• P/FCF Ratio: 21.24
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 64 Neutral
• Price Target: ¥1,264.00 ▲(9.91% Upside)
• Action: Downgraded Date: 11/18/25
• Date: Action: Downgraded 11/18/25

HYUGA PRIMARY CARE Co.,Ltd. has a strong financial foundation, which is the most significant factor in its overall score. However, the technical analysis indicates bearish momentum, which negatively impacts the stock's attractiveness. The valuation is neutral, providing neither a strong upside nor downside. The absence of earnings call and corporate events data means these factors do not influence the score.

Positive Factors

Strong revenue growth

Sustained ~20.8% revenue growth signals expanding service demand and successful patient/contract scaling in its care facilities. Over 2-6 months this underpins durable top-line momentum, supports pricing power, and provides a base for margin improvement and reinvestment.

Robust cash generation

Consistent free cash flow and strong operating cash flows indicate the company funds operations and expansions internally, reducing reliance on external financing. Durable cash generation supports capex, working capital, debt management, and shareholder returns over the medium term.

Healthy profitability and margins

Sustained gross, EBIT and net margins reflect operational efficiency in care delivery and cost control. Margin durability supports cash conversion and resilience to cost volatility, enabling long-term investment in services and maintaining competitive positioning.

Negative Factors

Rising total liabilities

An increase in total liabilities, despite managed leverage, raises structural risk if interest rates or funding costs rise. Over months this can constrain flexibility for M&A or capex, require higher cash generation to service liabilities, and increase refinancing risk.

Limited investor disclosure/guidance

Absence of regular earnings call content and formal guidance reduces forward visibility for investors and limits insight into management's strategy and forecasts. Structurally, this can impede market confidence and complicate capital allocation assessment over multiple quarters.

Earnings growth lags revenue growth

EPS growth (~9.6%) well below revenue expansion (~20.8%) suggests slower earnings leverage, possibly from reinvestment, higher operating costs, or non-operating items. Persisting divergence could signal margin pressure or inefficient conversion of sales to earnings over the medium term.

HYUGA PRIMARY CARE Co.,Ltd. Business Overview & Revenue Model

Company Description

HYUGA PRIMARY CARE Co.,Ltd. provides home-visit pharmacies, nursing, and care planning services in Japan. The company offers know-how, systems, human resources, and sales for home visiting pharmacy operations to small and medium-sized pharmacy operators; lends Fam Care, an home visit support information system; On-call system support; and guidance on home palliative care. It also provides Tai Support, a nursing facility search site that offers medical social workers with information on senior housing with services, paid nursing homes, group homes, etc.; Mimamori ICT Robot Terminal, a wearable device for nursing care facilities; operates a home visiting pharmacy that delivers prescription drugs directly to patients; and engages in the primary care home business. The company was formerly known as Hyuga Pharmacy Co., Ltd. and changed its name to HYUGA PRIMARY CARE Co.,Ltd. in October 2020. HYUGA PRIMARY CARE Co.,Ltd. was incorporated in 2007 and is based in Kasuga, Japan.

How the Company Makes Money

HYUGA PRIMARY CARE generates revenue primarily through the provision of medical services to patients, including consultation fees, diagnostic tests, and treatment plans. The company also benefits from partnerships with health insurance providers, allowing it to receive reimbursements for covered services delivered to insured patients. Additionally, the company may engage in government contracts or collaborations with healthcare organizations that provide funding or incentives for preventive care initiatives. Other potential revenue streams include subscription-based health management programs and telemedicine services, which provide a steady income from patients seeking convenient healthcare solutions.

HYUGA PRIMARY CARE Co.,Ltd. Financial Statement Overview

Summary

HYUGA PRIMARY CARE Co.,Ltd. exhibits strong financial performance with impressive revenue growth, profitability, and cash flow management. The balance sheet shows disciplined leverage and equity management, although rising liabilities require attention.

Income Statement

HYUGA PRIMARY CARE Co.,Ltd. has demonstrated strong revenue growth over recent years, with a notable increase from 4,331 million JPY in 2020 to 9,984 million JPY in 2025. The company has maintained healthy gross profit and net profit margins, indicating efficient cost management and profitability. The EBIT and EBITDA margins further highlight operational efficiency, contributing to a strong financial position.

Balance Sheet

The company's balance sheet reflects a solid equity base, with stockholders' equity increasing significantly over the years. The debt-to-equity ratio has been managed well, showing a stable leverage position. Return on equity has improved, indicating effective use of shareholder funds. However, the total liabilities have also increased, necessitating careful financial management to maintain stability.

Cash Flow

HYUGA PRIMARY CARE Co.,Ltd. has shown consistent growth in free cash flow, supported by strong operating cash flows. The operating cash flow to net income ratio is robust, indicating good cash generation relative to earnings. Despite fluctuations in capital expenditures, the company has managed to maintain positive free cash flow, supporting its operational and expansion activities.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	10.33B	9.98B	8.29B	6.66B	5.78B	5.09B
Gross Profit	2.41B	2.41B	1.88B	1.56B	1.24B	783.83M
EBITDA	1.27B	1.31B	854.38M	627.27M	568.69M	258.55M
Net Income	688.09M	719.03M	441.03M	382.88M	328.45M	97.14M
Balance Sheet
Total Assets	8.02B	7.05B	6.35B	2.91B	2.53B	2.02B
Cash, Cash Equivalents and Short-Term Investments	869.34M	565.93M	688.01M	567.69M	719.56M	538.29M
Total Debt	3.12B	2.65B	2.80B	251.54M	330.21M	447.63M
Total Liabilities	5.72B	4.68B	4.71B	1.43B	1.46B	1.41B
Stockholders Equity	2.29B	2.37B	1.64B	1.48B	1.07B	609.46M
Cash Flow
Free Cash Flow	0.00	485.51M	473.20M	102.59M	228.92M	277.22M
Operating Cash Flow	0.00	771.32M	706.64M	342.25M	484.60M	351.82M
Investing Cash Flow	0.00	-473.98M	-1.13B	-383.39M	-320.25M	-77.59M
Financing Cash Flow	0.00	-419.43M	538.78M	-110.73M	16.93M	36.64M

HYUGA PRIMARY CARE Co.,Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1150.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7133, the sentiment is Negative. The current price of 1150 is above the 20-day moving average (MA) of 1134.10, below the 50-day MA of 1155.52, and below the 200-day MA of 1289.27, indicating a bearish trend. The MACD of -29.89 indicates Positive momentum. The RSI at 32.74 is Neutral, neither overbought nor oversold. The STOCH value of 31.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7133.

HYUGA PRIMARY CARE Co.,Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2374	75 Outperform	¥30.28B	17.64	―	2.48%	3.88%	0.31%
2425	75 Outperform	¥3.03B	13.13	―	2.56%	-3.06%	-38.56%
7091	71 Outperform	¥5.52B	11.44	―	―	16.12%	107.25%
7129	68 Neutral	¥3.31B	63.45	―	2.64%	4.69%	103.59%
7133	64 Neutral	¥7.82B	13.42	―	1.80%	18.58%	-6.30%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
7061	45 Neutral	¥7.63B	27.36	―	1.41%	18.03%	-11.68%